Oligonucleotide Therapeutics: Drug Discovery Through Tightly Coupled Chemistry and Biology
Designing effective oligonucleotide therapeutics for clinical applications involves understanding both the chemistry and biology of nucleic acids.
In this white paper, learn about recent advances in chemical modifications for oligonucleotide therapeutics that improve stability and selectivity, biological screening assays to support lead optimization, and bioanalytical platforms that address the challenges of quantifying oligonucleotides.
Check out our comprehensive platform of oligonucleotide-related services by clicking here
Oligonucleotide Therapeutics_Drug Discovery White Paper
Related Content
RNA therapeutics can target specific mRNAs with high specificity, making them advantageous for treating genetic diseases caused by known mutations....
VIEW RESOURCESince the approval of the first siRNA drug in 2018, oligonucleotide therapeutics have rapidly emerged as a promising drug modality. ...
VIEW RESOURCE